Upper GIs: Investigating the Self-Care Market for Upper Gastrointestinals
This report is an in-depth exploration of the Upper Gastrointestinals market, including antacids, antiflatulents, antinauseants, digestive enzymes and liver & bile remedies and includes coverage of 15 major markets from across the globe, with topline sales, brand performances, regulatory developments, launches and ad campaigns.
With mid-year sales from DB6 2017, data includes topline historical sales for region, country and category, plus individual brand performances and forecasts to 2021 and 2026 for all categories and countries, plus a look ahead at what the future holds for the Upper GIs market globally.
The report also includes: an in-depth look at the latest scientific studies and case studies of key brands, highlighting success factors, sales, NPD and advertising activity.
Taking a look at the large antacids category (65% of upper GIs sales), it clearly faces challenges, but there are opportunities too. It is crowded, with traditional brands vying with newer PPIs in many markets, while H2 antagonists struggle to find a niche. PPIs provided a boost to the large US market, and have helped sustain growth in other markets like Australia and the UK, while in others they remain Rx and represent a potential switch opportunity. Meanwhile, traditional antacids are fighting back against the tide of newer brands, benefiting from lower price point and faster onset of action. Another sizeable category, liver & bile remedies generated the vast majority of sales in Europe and E&SE Asia, where a wave of activity has driven strong growth and category development. Combating liver fatgue is a key focus in Japan and Korea, while an increasing MNC presence contributed to a sizeable upturn in China. The small but dynamic antinauseants category has weathered challenges such as increased restrictions on ingredients. Most popular in Europe, digestive enzymes are split between established pancreatin products, ofen positioned for overindulgence, and lactase products for patients with lactose intolerance.